3094 in the Eastern District of Pennsylvania, up from roughly 1,800 in August 2025
Acute Gallbladder Disease: Zepbound (tirzepatide), other GLP-1 receptor agonists, and weight loss are associated with an increased chance of acute gallbladder disease
What is not known yet All three records show no posted results, so the actual numbers whether metoprolol exposure shifted, how retatrutide exposure differed in end-stage renal disease, and what happened to measured GFR are not public
Fast injection creates turbulence
Plans are more likely to cover Wegovy, according to GoodRx, but a dwindling share let you get the drug without first going through barriers that may end up curtailing access
(KWQC) - When thinking of summer, we typically dont think of it being a time of illness